Article Text

PDF
Correspondence
DOG1 expression in phosphaturic mesenchymal tumour
  1. David Creytens,
  2. Jo Van Dorpe
  1. Department of Pathology, Ghent University and Ghent University Hospital, Ghent, Belgium
  1. Correspondence to Dr David Creytens, Department of Pathology, Ghent University Hospital, De Pintelaan 185, Ghent 9000, Belgium; creytensdavid{at}hotmail.com, david.creytens{at}uzgent.be

Statistics from Altmetric.com

Phosphaturic mesenchymal tumour (PMT) is a rare mesenchymal tumour, which most often occurs in middle-aged adults, either in soft tissue or bone.1 ,2 PMTs are variable in their histomorphological appearance but often show a mixture of bland spindle cells embedded in a highly vascular (hemangiopericytoma-like) myxochondroid matrix, mature fat and osteoclast-like giant cells (figure 1A, B). The differential diagnosis of PMT is broad. In most cases of PMT, the patient has a longstanding clinical history of osteomalacia, facilitating the diagnosis of PMT. However, unsuspected PMT may be histomorphologically confused with other giant cell containing bone tumours, including chondromyxoid fibromas and chondroblastomas. Recognition of the distinctive ‘grungy’-appearing calcified matrix is the best way to distinguish PMT from other tumours (figure 1B). Detection of Fibroblast Growth Factor (FGF23) expression is …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.